ask="4.72"
ask_size="200"
average_daily_volume="117031"
bid="3.14"
bid_size="100"
book_value="1.98"
change="+0.00"
change_from_200_day_moving_average="0.05"
change_from_50_day_moving_average="0.51"
change_from_52_week_high="-3.86"
change_From_52_week_low="1.07"
change_in_percent="+0.00%"
close="4.29"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.39"
ebitda="-35.85M"
eps_estimate_current_year="-2.28"
eps_estimate_next_quarter="-0.50"
eps_estimate_next_year="-2.14"
ex_dividend_date="N/A"
float_shares="8580000"
high="4.40"
high_52_weeks="8.15"
last_trade_date="1/17/2017"
last_trade_price="4.29"
last_trade_size="111"
last_trade_time="4:00pm"
low="4.15"
low_52_weeks="3.22"
market_capitalization="80.02M"
moving_average_200_day="4.24"
moving_average_50_day="3.78"
name="Catabasis Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="17.00"
open="4.30"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+1.22%"
percent_change_from_50_day_moving_average="+13.63%"
percent_change_from_52_week_high="-47.36%"
percent_change_from_52_week_low="+33.23%"
previous_close="4.29"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.17"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="18652000"
short_ratio="1.60"
stock_exchange="NGM"
symbol="CATB"
volume="104566"
weeks_range_52="3.22 - 8.15"
